ダウンロード数: 78
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
69_4_107.pdf | 749.87 kB | Adobe PDF | 見る/開く |
タイトル: | 膀胱原発印環細胞癌に対してGC療法が有効であった1例 |
その他のタイトル: | A Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder Showing Effectiveness of Chemotherapy with Gemcitabine and Cisplatin |
著者: | 石井, 信 山本, 致之 吉村, 明洋 林, 拓自 川村, 憲彦 永原, 啓 中井, 康友 中山, 雅志 西村, 和郎 |
著者名の別形: | ISHII, Makoto YAMAMOTO, Yoshiyuki YOSHIMURA, Akihiro HAYASHI, Takuji KAWAMURA, Norihiko NAGAHARA, Akira NAKAI, Yasutomo NAKAYAMA, Masashi NISHIMURA, Kazuo |
キーワード: | Bladder cancer Signet ring cell carcinoma Gemcitabine Cisplatin |
発行日: | 30-Apr-2023 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 69 |
号: | 4 |
開始ページ: | 107 |
終了ページ: | 112 |
抄録: | A 55-year-old female presented to the hospital with a complaint of gross hematuria. Transurethral resection of bladder tumor was performed. The specimens pathologically showed signet ring cells and no urothelial carcinoma components. Magnetic resonance imaging and computed tomographic (CT) scan revealed bladder tumor, cervical metastasis, bilateral ovarian metastasis, and multiple lymph node metastasis. She was diagnosed with a primary signet ring cell carcinoma of the urinary bladder with cT3bN2M1, and was treated with chemotherapy of gemcitabine and cisplatin combination (GC). After 2 cycles of GC, the value of CEA which was elevated to 106 ng/ml before treatment, became negative. CT scan showed that her disease had successfully responded to the chemotherapy, and remained efficacious till the end of 6 cycles. The patient subsequently received 1 cycle of gemcitabine and nedaplatin and 3 cycles of avelumab due to renal insufficiency. Yet, 14 months after diagnosis, cerebellar metastases appeared and the patient died of meningeal carcinomatosis. |
著作権等: | 許諾条件により本文は2024-05-01に公開 |
DOI: | 10.14989/ActaUrolJap_69_4_107 |
URI: | http://hdl.handle.net/2433/282079 |
PubMed ID: | 37183041 |
出現コレクション: | Vol.69 No.4 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。